Status:
UNKNOWN
Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy
Lead Sponsor:
Daewon Pharmaceutical Co., Ltd.
Conditions:
Dyslipidemias
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
A Multi-center, Randomized, Double-blind, Parallel Phase Ⅳ Study to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlle...
Eligibility Criteria
Inclusion
- both male and female who are over 19-year-old
- 200mg/dl≤TG\<500mg/dl
- Desired value of LDL-c
- very high risk \< 70
- high risk \< 100
- moderate risk \<130
- low risk \< 160
Exclusion
- patient who is going to have an operation during this study
- patient who has allergy or hypersensitivity of fenofibrate
- patient who has abnormal ECG
Key Trial Info
Start Date :
July 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2020
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT03874260
Start Date
July 25 2018
End Date
March 31 2020
Last Update
March 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hallym University Dongtan Sacred Heart Hospital
Hwaseong-si, South Korea